India’s Sun Pharma Targets US Dermatology Market with Dusa Pharmaceuticals Acquisition
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 11 (Table of Contents)
Published: 26 Nov-2012
DOI: 10.3833/pdr.v2012.i11.1839 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
India’s Sun Pharmaceutical Industries has agreed to acquire the US dermatology company Dusa Pharmaceuticals in a deal valued at approximately US$230 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS